MSU
WVE icon

Mizuho Securities USA’s Wave Life Sciences WVE Stock Holding History

Mizuho Securities USA’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50,000
Closed -$1.09M – 220
2017
Q3 		$1.09M Buy
+50,000
New +$1M 0.06% 108

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Mizuho Securities USA's WVE Position: Q4 2017 in Review

Mizuho Securities USA sold out of Wave Life Sciences (WVE) in Q4 2017, closing a stake of 50,000 shares — an estimated $1.09M sold.

Mizuho Securities USA first reported a position in WVE in Q3 2017 and held it in 1 quarter. The position peaked at $1.09M in Q3 2017. 73 funds tracked by Wall St. Rank hold WVE as of Q4 2017.

  • Mizuho Securities USA reported no remaining Wave Life Sciences position as of Q4 2017 after selling out during the quarter.
  • Mizuho Securities USA sold 50,000 Wave Life Sciences shares in Q4 2017, an estimated $1.09M.
  • Mizuho Securities USA first reported a position in Wave Life Sciences in Q3 2017 and held it in 1 quarter.
  • Mizuho Securities USA's Wave Life Sciences position peaked at $1.09M in Q3 2017.
  • 73 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2017.

Based on Mizuho Securities USA's 13F filing for Q4 2017, filed 24 Jan 2018.